- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.01 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x SF4: IRON/SULFUR CLUSTER(Non-covalent)
- 2 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
FMN.5: 24 residues within 4Å:- Chain A: A.549, S.550, A.551, A.552, K.574, T.575, I.590, N.609, E.611, N.668, K.709, T.735, N.736, T.737, S.766, G.767, T.793, G.794, G.795, V.815, C.816, S.817, Q.820
- Ligands: URF.8
21 PLIP interactions:21 interactions with chain A- Hydrophobic interactions: A:A.552, A:I.590, A:N.609
- Hydrogen bonds: A:S.550, A:T.575, A:T.575, A:T.575, A:N.668, A:K.709, A:K.709, A:K.709, A:N.736, A:S.766, A:G.767, A:T.793, A:G.795, A:C.816, A:S.817
- Water bridges: A:S.550, A:G.794, A:G.794
FMN.13: 24 residues within 4Å:- Chain B: A.549, S.550, A.551, A.552, K.574, T.575, I.590, N.609, E.611, N.668, K.709, T.735, N.736, T.737, S.766, G.767, T.793, G.794, G.795, V.815, C.816, S.817, Q.820
- Ligands: URF.16
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:A.552, B:I.590, B:N.609
- Hydrogen bonds: B:S.550, B:T.575, B:T.575, B:T.575, B:N.668, B:K.709, B:K.709, B:K.709, B:N.736, B:S.766, B:G.767, B:G.795, B:C.816, B:S.817
- Water bridges: B:S.550, B:G.794, B:G.794
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.6: 33 residues within 4Å:- Chain A: V.129, P.131, G.194, A.195, G.196, P.197, A.198, F.217, E.218, K.219, Q.220, G.225, L.226, E.230, I.231, R.235, K.259, S.260, L.261, G.282, I.283, G.284, P.286, L.310, D.342, T.343, D.346, V.447, G.480, D.481, T.488, T.489, S.492
26 PLIP interactions:26 interactions with chain A- Hydrophobic interactions: A:L.226, A:L.226, A:L.310, A:T.343
- Hydrogen bonds: A:V.129, A:A.195, A:A.198, A:K.219, A:G.225, A:L.226, A:R.235, A:R.235, A:L.261, A:L.261, A:D.342, A:D.481, A:T.489, A:T.489, A:S.492, A:S.492
- Water bridges: A:Q.220, A:Y.222, A:G.284, A:L.285, A:L.285, A:V.490
FAD.14: 33 residues within 4Å:- Chain B: V.129, P.131, G.194, A.195, G.196, P.197, A.198, F.217, E.218, K.219, Q.220, G.225, L.226, E.230, I.231, R.235, K.259, S.260, L.261, G.282, I.283, G.284, P.286, L.310, T.343, D.346, V.447, G.480, D.481, T.488, T.489, S.492
- Ligands: NDP.15
26 PLIP interactions:26 interactions with chain B- Hydrophobic interactions: B:L.310, B:T.343
- Hydrogen bonds: B:V.129, B:A.195, B:A.195, B:A.198, B:K.219, B:G.225, B:L.226, B:R.235, B:R.235, B:L.261, B:L.261, B:D.481, B:T.489, B:T.489, B:S.492, B:S.492
- Water bridges: B:S.199, B:Q.220, B:Y.222, B:D.481, B:I.482, B:N.487, B:T.489, B:V.490
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.7: 18 residues within 4Å:- Chain A: K.289, D.291, G.339, A.340, G.341, D.342, T.343, R.364, K.365, R.371, P.393, A.437, F.438, G.439, G.484, M.485, A.486, N.487
30 PLIP interactions:30 interactions with chain A- Hydrogen bonds: A:K.289, A:D.291, A:D.291, A:A.340, A:T.343, A:T.343, A:R.364, A:A.437, A:S.440, A:G.484
- Water bridges: A:G.341, A:D.342, A:T.343, A:A.344, A:R.364, A:R.364, A:R.364, A:S.440, A:G.484, A:N.487, A:N.487, A:N.487
- Salt bridges: A:R.364, A:K.365, A:R.371, A:R.371
- pi-Stacking: A:F.438, A:F.438
- pi-Cation interactions: A:R.364, A:R.364
NDP.15: 18 residues within 4Å:- Chain A: K.47
- Chain B: K.289, G.339, A.340, G.341, D.342, T.343, R.364, K.365, R.371, P.393, A.437, F.438, G.439, A.486, N.487, T.488
- Ligands: FAD.14
39 PLIP interactions:37 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:N.487
- Hydrogen bonds: B:K.289, B:A.340, B:D.342, B:D.342, B:T.343, B:R.364, B:N.487, A:K.47, A:K.47
- Water bridges: B:D.134, B:D.291, B:G.341, B:T.343, B:A.344, B:R.364, B:R.364, B:R.364, B:R.364, B:K.365, B:R.371, B:S.392, B:F.438, B:G.439, B:S.440, B:S.440, B:S.440, B:D.481, B:D.481, B:D.481, B:D.481, B:D.481
- Salt bridges: B:R.364, B:K.365, B:R.371
- pi-Stacking: B:F.438, B:F.438
- pi-Cation interactions: B:R.364, B:R.364
- 2 x URF: 5-FLUOROURACIL(Non-covalent)
URF.8: 9 residues within 4Å:- Chain A: N.609, E.611, L.612, I.613, N.668, S.670, N.736, T.737
- Ligands: FMN.5
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:N.609, A:N.609, A:N.668, A:S.670, A:N.736, A:N.736, A:T.737
URF.16: 9 residues within 4Å:- Chain B: N.609, E.611, L.612, I.613, N.668, S.670, N.736, T.737
- Ligands: FMN.13
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:N.609, B:N.609, B:N.668, B:S.670, B:N.736, B:N.736, B:T.737
- Water bridges: B:G.764
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dobritzsch, D. et al., Crystal Structure of Dihydropyrimidine Dehydrogenase, a Major Determinant of the Pharmacokinetics of the Anti-Cancer Drug 5-Fluorouracil. Embo J. (2001)
- Release Date
- 2001-02-23
- Peptides
- DIHYDROPYRIMIDINE DEHYDROGENASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.01 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x SF4: IRON/SULFUR CLUSTER(Non-covalent)
- 2 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x URF: 5-FLUOROURACIL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dobritzsch, D. et al., Crystal Structure of Dihydropyrimidine Dehydrogenase, a Major Determinant of the Pharmacokinetics of the Anti-Cancer Drug 5-Fluorouracil. Embo J. (2001)
- Release Date
- 2001-02-23
- Peptides
- DIHYDROPYRIMIDINE DEHYDROGENASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D